BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8225485)

  • 1. An improved 32P-postlabelling assay for detection and quantitation of styrene 7,8-oxide-DNA adducts.
    Cantoreggi S; Gupta RC; Lutz WK
    IARC Sci Publ; 1993; (124):201-5. PubMed ID: 8225485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 32P-postlabelling analysis of small aromatic and of bulky non-aromatic DNA adducts.
    Reddy MV
    IARC Sci Publ; 1993; (124):25-34. PubMed ID: 8225492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 32P-postlabelling analysis of bulky aromatic adducts.
    Gupta RC
    IARC Sci Publ; 1993; (124):11-23. PubMed ID: 8225473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-postlabelling of DNA adducts in styrene oxide-modified DNA and in workers exposed to styrene.
    Vodicka P; Hemminki K
    IARC Sci Publ; 1993; (127):109-18. PubMed ID: 8070856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 32P-Postlabeling analysis of DNA adducts of styrene 7,8-oxide at the O6-position of guanine.
    Otteneder M; Eder E; Lutz WK
    Chem Res Toxicol; 1999 Jan; 12(1):93-9. PubMed ID: 9894023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
    Wohlin P; Zeisig M; Gustafsson JA; Möller L
    Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 32P-Post-labelling method improvements for aromatic compound-related molecular epidemiology studies.
    Munnia A; Saletta F; Allione A; Piro S; Confortini M; Matullo G; Peluso M
    Mutagenesis; 2007 Nov; 22(6):381-5. PubMed ID: 17716983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 32P-postlabelling methods for cyclic DNA adducts.
    Watson WP; Crane AE; Steiner S
    IARC Sci Publ; 1993; (124):255-62. PubMed ID: 8225493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical (postlabelling) methods for analysis of carcinogen-DNA adducts.
    Randerath K; Randerath E; Agrawal HP; Reddy MV
    IARC Sci Publ; 1984; (59):217-31. PubMed ID: 6443609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
    Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A
    IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of an interlaboratory trial of 32P-postlabelling.
    Phillips DH; Castegnaro M
    IARC Sci Publ; 1993; (124):35-49. PubMed ID: 8225506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoaffinity clean-up combined with 32P-postlabelling analysis of 1,N6-ethenoadenine and 3,N4-ethenocytosine in DNA.
    Guichard Y; Nair J; Barbin A; Bartsch H
    IARC Sci Publ; 1993; (124):263-9. PubMed ID: 8225494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvements in the 32P-postlabelling procedure to quantify bulky aromatic DNA adducts.
    Steenwinkel MJ; Roggeband R; van Delft JH; Baan RA
    IARC Sci Publ; 1993; (124):65-70. PubMed ID: 7693587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach.
    Eder E; Schuler D; Budiawan
    IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 32P-postlabelling method for the detection of 7-alkylguanine adducts formed by the reaction of different 1,2-alkyl epoxides with DNA.
    Kumar R; Staffas J; Försti A; Hemminki K
    Carcinogenesis; 1995 Mar; 16(3):483-9. PubMed ID: 7697802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of bulky DNA adducts by the regular and a modified 32P-postlabelling assay; influence of the DNA-isolation method.
    Kovács K; Anna L; Rudnai P; Schoket B
    Mutat Res; 2011 Mar; 721(1):95-100. PubMed ID: 21237286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of polycyclic aromatic hydrocarbon-DNA adducts by postlabelling with the weak beta-emitters 35S-phosphorothioate and 33P-phosphate, immobilized boronate chromatography and high-performance liquid chromatography.
    Baird WM; Lau HH; Schmerold I; Coffing SL; Brozich SL; Lee H; Harvey RG
    IARC Sci Publ; 1993; (124):217-26. PubMed ID: 8225488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tissue fixation on recovery of DNA adducts in the 32P-postlabelling assay.
    Hewer A; Phillips DH
    IARC Sci Publ; 1993; (124):211-4. PubMed ID: 8225487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA adducts of the antitumor agent diaziquone.
    Gupta RC; Garg A; Earley K; Agarwal SC; Lambert GR; Nesnow S
    Cancer Res; 1991 Oct; 51(19):5198-204. PubMed ID: 1913643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.